Report: pharmacotherapy for moderate to severe inflammatory bowel disease: evolving strategies.

Report: pharmacotherapy for moderate to severe inflammatory bowel disease: evolving strategies. Am J Manag Care. 2016 03; 22(3 Suppl):s39-50.

View in: PubMed